Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference

<br /> Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference<br />

PR Newswire

NORWOOD, Mass.

,

Sept. 12, 2022

/PRNewswire/ — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that

Yuval Cohen

, Ph.D., Chief Executive Officer of Corbus, will present virtually at the H.C. Wainwright 24th Annual Global Investment Conference. The hybrid conference will take place

September 12-14

, 2022.

A livestream of the virtual presentation is available on-demand beginning today,

Monday, September 12, 2022

at

7:00 AM ET

for those who are registered to attend the conference and will be accessible for 30 days on the H.C. Wainwright conference platform. For more information, please visit the

conference website

.

About Corbus

Corbus is an immunology company committed to helping people defeat serious illness by bringing innovative scientific approaches to well understood biological pathways. Corbus’ current pipeline includes anti-integrin monoclonal antibodies that block activation of TGFβ and small molecules that activate or inhibit the endocannabinoid system. Corbus is headquartered in

Norwood, Massachusetts

. For more information on Corbus, visit

corbuspharma.com

. Connect with us on

Twitter

,

LinkedIn

and

Facebook

.